Valentia Analytical’s Exhibition and Poster on Uncovering Critical Method Attributes at World’s ADC San Diego 2024
Valentia Analytical was thrilled to exhibit at the 2024 World’s ADC Conference November 2024 in San Diego, a pivotal gathering of industry experts specializing in Antibody Drug Conjugates (ADCs). This prestigious event showcased insightful presentations and engaging workshops, serving as an essential platform for professionals to discuss the forefront of ADC innovation and tackle the sector’s pressing challenges. Valentia’s booth was strategically positioned to interact with numerous attendees, making it an ideal spot for showcasing our advanced analytical services and engaging in meaningful dialogues about the complexities involved in ADC development.
In addition to the booth, Valentia Analytical proudly presented a scientific poster titled “Ensuring Analytical Excellence: Uncovering Critical Method Attributes Through Systematic, Data-Driven Methodologies.” This poster addressed the necessity for precise analytical methods in assessing the safety, efficacy, and quality of proteins, peptides, monoclonal antibodies, ADCs, and small molecules. The presentation emphasized a systematic, data-driven approach to method development, aimed at revealing critical quality attributes often overlooked due to the complexity of samples and analytical instruments. Key focuses included issues such as protein adsorption to system components, the effects of sample solvents, and undesired secondary interactions, with an aim to initiate early interventions to mitigate these effects, thereby ensuring robust and reliable methods.
We are deeply grateful for the opportunity to connect with an incredible number of industry professionals who showed potential interest to collaborate. This event has opened doors to new opportunities to support and enhance current and future analytics, reinforcing Valentia’s commitment to delivering medicine to patients fast. Valentia’s comprehensive suite of services, including Bioassay (Cytotoxicity, ADCC), UHPLC, HPLC, ion-exchange, size-exclusion, and affinity chromatography, is designed to meet the rigorous demands of ADC products. Through our presentation and interactions at the conference, Valentia Analytical has further solidified its reputation as a leader in providing precise, reliable analytical outcomes that support all phases of drug development and ensure compliance with regulatory standards. Valentia’s structured, data-driven approach to method development, rooted in a robust historical database, not only meets but sets new standards for analytical method quality, ensuring the highest level of reliability and reproducibility in its results.